Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 21

Results For "RET"

1730 News Found

Healthcare policymakers lay thrust on genetic screening and indigenous therapies for rare diseases
Public Health | May 05, 2026

Healthcare policymakers lay thrust on genetic screening and indigenous therapies for rare diseases

Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access


India and Japan deepen healthcare collaboration at 3rd joint committee meeting
Policy | May 05, 2026

India and Japan deepen healthcare collaboration at 3rd joint committee meeting

Discussions focused on digital health, non-communicable diseases, resilient supply chains, medical innovation, and healthcare workforce development


SK Capital sells Noramco assets to Siegfried
News | May 05, 2026

SK Capital sells Noramco assets to Siegfried

Keeps Halo Pharma to drive independent growth


C-CAMP launches NBEC 2026 with up to Rs 20 Crore in prizes and investment opportunities
Biopharma | May 04, 2026

C-CAMP launches NBEC 2026 with up to Rs 20 Crore in prizes and investment opportunities

India’s largest life sciences entrepreneurship competition opens applications for startups, innovators and student teams nationwide


Moderna posts Q1 2026 loss despite revenue surge
News | May 04, 2026

Moderna posts Q1 2026 loss despite revenue surge

Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets


Health ministry releases new healthcare safety guidelines
Policy | May 04, 2026

Health ministry releases new healthcare safety guidelines

Week-long Fire Safety Week 2026 campaign focuses on strengthening fire prevention, preparedness, audits, and emergency response across hospitals and healthcare facilities


Lilly posts explosive Q1 2026 results
News | May 04, 2026

Lilly posts explosive Q1 2026 results

Lifts full-year outlook as obesity drug boom accelerates


FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win
News | May 02, 2026

FDA renews IQOS “reduced-risk” status backing PMI’s smoke-free strategy in regulatory win

The renewal covers two versions of the IQOS device and three HEETS tobacco variants


Gilead completes $7.8B Arcellx acquisition & takes full control of Myeloma CAR-T candidate
News | May 02, 2026

Gilead completes $7.8B Arcellx acquisition & takes full control of Myeloma CAR-T candidate

Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right


Inside India’s qPCR Transformation: Scale, Shift, and Structural Change
Opinion | May 01, 2026

Inside India’s qPCR Transformation: Scale, Shift, and Structural Change

Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine